) -- Shares of

Synta Pharmaceuticals



) were gapping up Monday morning with an open price 13.2% higher than Friday's closing price. The stock closed at $5.29 Friday and opened today's trading at $5.99.

The average volume for Synta has been 180,400 shares per day over the past 30 days. Synta has a market cap of $207.6 million and is part of the

health care

sector and


industry. Shares are down 13.6% year to date as of the close of trading on Friday.

Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases.

TheStreet Ratings rates Synta as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. You can view the full

Synta Ratings Report


Get more investment ideas from our

investment research center